Bionano Genomics Inc (BNGO) Quarterly Institutional 13F Update (Q2 2026)

BNGO ranks #7093 out of 37507 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

35 institutions disclose a position in BNGO, but none treat it as a major bet — even Gsa Capital Partners LLP, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

Carret Asset Management, LLC has added to its BNGO position for two straight quarters, increasing it by $73.8K to reach $141.3K today.

Gsa Capital Partners LLP has trimmed its BNGO position for two straight quarters, cutting it by $347.0K while still holding $170.0K.

BNGO reported a net loss of $32.2M over the trailing twelve months.

• Not yet profitable — net loss of $32.2M over the trailing twelve months
• Revenue grew 10.0% year over year
• Net income improved year over year, from -$74.3M to -$32.2M
• Operating cash flow was negative, using $16.3M in cash
• Current ratio of 1.98x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.66x equity — within a conventional range